Komori
Rigaku Holdings (268A) · TargetLower first-half revenue and increased orders from the third quarter onward

Overseas Growth in Multipurpose Analytical Instruments

First written in FY2024. 1 of 8 entries say "Worsened", first in 2026-05-13. Latest entry: FY2026-H1.

8entries
2years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2024 – FY2025Softened2026-05-132025: 220252026: 62026
Same theme, other companies
Overseas Growth in Multipurpose Analytical InstrumentsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026-H1Lower first-half revenue and increased orders from the third quarter onwardAnnual report

    「The multi-purpose analytical instruments business recorded revenue of ¥15,081 million, down 17.1% year on year, against a weakening market environment caused by the continued impact of policies under the Trump administration in the United States and fluctuations in energy prices resulting from the situation in the Middle East. At the same time, demand for semiconductors and electronic components is increasing, and orders have risen toward the third quarter and beyond.」

    The multi-purpose analytical instruments business recorded a 17.1% year-on-year revenue decline, while orders for the third quarter onward increased on higher demand from the semiconductor and electronic components industries. No change to the approximately 7% average annual growth target was disclosed.
  2. FY2025Overall revenue decline and recovery in the second halfAnnual report

    「In the multi-purpose analytical instruments business, revenue declined 2.2% year on year for the full year due to lower revenue in the Americas and China.」

    Multi-purpose analytical instruments revenue declined 2.2% for the full year, while Europe, Japan and other parts of Asia grew in the fourth quarter, indicating a recovery in demand in the second half. The approximately 7% average annual growth target remains unchanged.
  3. FY2025-H1Regional progress and overall revenue declineAnnual report

    「At the same time, our ongoing global strategy has begun to bear fruit, with revenue increasing 7.1% year on year in the Americas, Asia excluding China and Europe.」

    Although the multi-purpose analytical instruments business as a whole recorded a 13.5% year-on-year revenue decline, revenue increased 7.1% year on year in the Americas, Asia excluding China and Europe. The disclosure presents regional progress alongside the overall decline.
  4. FY2024First statedAnnual report

    「We aim to increase our sales share in global markets and achieve average annual revenue growth of approximately 7% in the multi-purpose analytical instruments field, exceeding the 5.5% CAGR of the X-ray diffraction (XRD) and X-ray fluorescence (XRF) analytical instruments markets from 2023 to 2027.」

    The Group has set a target of approximately 7% average annual revenue growth from 2023 to 2027 for multi-purpose analytical instruments through investment in overseas sales, service and application personnel and laboratories.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Rigaku Holdings yet. It last moved in the Earnings presentation of 2026-08-07: "Other".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.